F. Lejeune

2.5k total citations
35 papers, 761 citations indexed

About

F. Lejeune is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, F. Lejeune has authored 35 papers receiving a total of 761 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 12 papers in Molecular Biology and 9 papers in Immunology. Recurrent topics in F. Lejeune's work include Cutaneous Melanoma Detection and Management (8 papers), Immunotherapy and Immune Responses (7 papers) and Sarcoma Diagnosis and Treatment (4 papers). F. Lejeune is often cited by papers focused on Cutaneous Melanoma Detection and Management (8 papers), Immunotherapy and Immune Responses (7 papers) and Sarcoma Diagnosis and Treatment (4 papers). F. Lejeune collaborates with scholars based in Switzerland, Belgium and France. F. Lejeune's co-authors include G. Hamilton Fairley, G A Currie, D. Liénard, A. M. M. Eggermont, Nathalie Renard, Laurence Lespagnard, R Heimann, Léonidas Zografos, Serge Leyvraz and Thierry Dorval and has published in prestigious journals such as Journal of Clinical Oncology, Annals of the New York Academy of Sciences and Annals of Oncology.

In The Last Decade

F. Lejeune

33 papers receiving 715 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
F. Lejeune Switzerland	15	351	210	192	156	110	35	761
Christophe Chantrain Belgium	15	335 1.0×	107 0.5×	365 1.9×	146 0.9×	35 0.3×	43	915
Umberto M. Reali Italy	15	384 1.1×	187 0.9×	213 1.1×	54 0.3×	16 0.1×	39	758
Fiona Zhong United States	9	258 0.7×	376 1.8×	309 1.6×	46 0.3×	31 0.3×	13	908
Udo Siebolts Germany	16	208 0.6×	52 0.2×	289 1.5×	91 0.6×	35 0.3×	61	797
Takeo Isozaki Japan	20	312 0.9×	324 1.5×	244 1.3×	78 0.5×	16 0.1×	55	930
Kaiming Zhang China	20	266 0.8×	547 2.6×	573 3.0×	44 0.3×	215 2.0×	91	1.3k
Rebeca Galisteo United States	14	254 0.7×	185 0.9×	359 1.9×	99 0.6×	44 0.4×	18	840
A. Kerber Germany	13	187 0.5×	132 0.6×	155 0.8×	47 0.3×	19 0.2×	28	536
Christopher Geehan United States	11	251 0.7×	424 2.0×	335 1.7×	51 0.3×	30 0.3×	12	924
Xianbo Zuo China	21	113 0.3×	324 1.5×	391 2.0×	66 0.4×	39 0.4×	95	1.0k

Countries citing papers authored by F. Lejeune

Since Specialization

Citations

This map shows the geographic impact of F. Lejeune's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Lejeune with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Lejeune more than expected).

Fields of papers citing papers by F. Lejeune

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Lejeune. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Lejeune. The network helps show where F. Lejeune may publish in the future.

Co-authorship network of co-authors of F. Lejeune

This figure shows the co-authorship network connecting the top 25 collaborators of F. Lejeune. A scholar is included among the top collaborators of F. Lejeune based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. Lejeune. F. Lejeune is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Testori, Alessandro, Javier Soteldo, B. Powell, et al.. (2016). ecancermedicalscience. ecancermedicalscience. 7. 294–294. 6 indexed citations

Matter, Maurice, Marie Nicod Lalonde, Ariane Boubaker, et al.. (2007). The Role of Interval Nodes in Sentinel Lymph Node Mapping and Dissection for Melanoma Patients. Journal of Nuclear Medicine. 48(10). 1607–1613. 21 indexed citations

Sauro, Carolina Lo, et al.. (2006). Stress e disturbi alimentari psicogeni. Giornale italiano di psicopatologia/Journal of psychopathology/Italian journal of psychopathology. 12.

Bonvalot, Sylvie, A. Laplanche, F. Lejeune, et al.. (2005). Limb salvage with isolated perfusion for soft tissue sarcoma: could less TNF-α be better?. Annals of Oncology. 16(7). 1061–1068. 90 indexed citations

Bröcker, Eva-Bettina, F. Lejeune, Cécile Chartier, et al.. (1999). Adjuvant trial in melanoma patients comparing rIFN-α to rIFN-γ to Iscador to a control group after curative resection of high risk primary (≥3 MM) or regional lymphnode metastasis (EORTC 18871). European Journal of Cancer. 35. S82–S82. 48 indexed citations

Leyvraz, Serge, Vito Spataro, J. Bauer, et al.. (1997). Treatment of ocular melanoma metastatic to the liver by hepatic arterial chemotherapy.. Journal of Clinical Oncology. 15(7). 2589–2595. 130 indexed citations

Lejeune, F., et al.. (1996). [Large abdominal wall reconstruction by free flap after recurrence of a dermatofibrosarcoma protuberans].. PubMed. 41(6). 660–5. 9 indexed citations

Tchernia, G, et al.. (1996). Erythroblastic and/or Megakaryoblastic Leukemia in Down Syndrome. Journal of Pediatric Hematology/Oncology. 18(1). 59–62. 20 indexed citations

Romero, Pedro, et al.. (1995). HLA-A2 restricted CTL responses to melanocyte differentiation antigens in melanoma patients subjected to high-dose TNF-α administered by isolated limb perfusion. Melanoma Research. 5. 30–30. 1 indexed citations

10.

Lejeune, F.. (1995). 4 Regional treatment with TNF-alpha and chemotheraphy. European Journal of Cancer. 31. S1–S1. 1 indexed citations

11.

Renard, Nathalie, D. Liénard, Laurence Lespagnard, et al.. (1994). Harly endothelium activation and polymorphonuclear cell invasion precede specific necrosis of human melanoma and sarcoma treated by intravascular high‐dose tumour necrosis factor alpha (rTNFα). International Journal of Cancer. 57(5). 656–663. 127 indexed citations

12.

Liénard, D., et al.. (1993). Local Administration of α‐MSH Exerts a Trophic Effect on the 200‐kDa Neurofilament in Sciatic Rat Nerve. Annals of the New York Academy of Sciences. 680(1). 655–659. 1 indexed citations

13.

Lejeune, F., et al.. (1993). Labelled polycyanoacrylate nanoparticles for human In Vivo use. Applied Radiation and Isotopes. 44(9). 1219–1224. 17 indexed citations

14.

Ghanem, G., et al.. (1992). Partial characterization of IR-α-MSH peptides found in melanoma tumors. Peptides. 13(5). 989–994. 17 indexed citations

15.

Autier, Philippe, M. Joarlette, F. Lejeune, et al.. (1991). Cutaneous malignant melanoma and exposure to sunlamps and sunbeds. Melanoma Research. 1(1). 69–69. 36 indexed citations

16.

Vercammen, Ans, et al.. (1991). Human melanoma targeting with α-MSH-melphalan conjugate. Melanoma Research. 1(2). 105–114. 16 indexed citations

17.

Tueni, Elias, Patrick Dumont, Danielle Jacobovitz, et al.. (1987). Subrenal capsule assay for fresh human tumors in immunocompetent mice; an inappropriate technique for non-small cell lung cancer. European Journal of Cancer and Clinical Oncology. 23(8). 1163–1167. 5 indexed citations

18.

Ghanem, G., F. Legros, F. Lejeune, & J Frühling. (1982). Comparison and evaluation of different methods for α-MSH labelling. Journal of Immunological Methods. 54(2). 223–232. 5 indexed citations

19.

Currie, G A, F. Lejeune, & G. Hamilton Fairley. (1971). Immunization with Irradiated Tumour Cells and Specific Lymphocyte Cytotoxicity in Malignant Melanoma. BMJ. 2(5757). 305–310. 105 indexed citations

20.

Lejeune, F.. (1965). [Primary retroperitoneal tumors. Review of 22 cases].. PubMed. 64(3). 443–69. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact